Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06161831 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HPV Vaccine Reminders - SEARCH II Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completion pushed from Jul 31, 2026 to Nov 30, 2026 Interventions: Text Message/automated phone reminder (Behavioral) to Text Message/automated phone reminder (Behavioral) · Eligibility criteria expanded, about 8 words · Site details revised at 1 of 2 sites Show 3 more changesShow less
    • Interventions: Text Message/automated phone reminder (Behavioral) to Text Message/automated phone reminder (Behavioral)
    • Eligibility criteria expanded, about 8 words
    • Site details revised at 1 of 2 sites
  2. Primary completion date: Dec 31, 2025 to May 31, 2026 Completion date: Dec 31, 2025 to Jul 31, 2026v5 Show 1 more changeShow less
    • Completion date: Dec 31, 2025 to Jul 31, 2026
  3. Trial status: Recruiting to Active, Not Recruiting Primary completion date: May 31, 2026 to Dec 31, 2025 · Completion date: Jul 31, 2026 to Dec 31, 2025 · Site details revised at 2 of 2 sitesv4 Show 3 more changesShow less
    • Primary completion date: May 31, 2026 to Dec 31, 2025
    • Completion date: Jul 31, 2026 to Dec 31, 2025
    • Site details revised at 2 of 2 sites
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Mar 1, 2024 to Apr 22, 2024 · Site details revised at 2 of 2 sitesv3 Show 2 more changesShow less
    • Start date changed from estimate of Mar 1, 2024 to Apr 22, 2024
    • Site details revised at 2 of 2 sites
  5. Start date: Jan 1, 2024 to Mar 1, 2024 Primary completion date: Mar 31, 2026 to May 31, 2026v2 Show 1 more changeShow less
    • Primary completion date: Mar 31, 2026 to May 31, 2026
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text message and automated phone reminders on human papillomavirus (HPV) vaccination initiation and completion.
Trial Details
NCT Number NCT06161831
Lead Sponsor Columbia University
Collaborators: Makerere University, National Cancer Institute (NCI)
Conditions Human Papillomavirus Vaccination
Enrollment 396 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov